Headlines

NASDAQ:DRTX

FB Nasdaq FB Facebook

Biotech Losers: Agenus Inc (NASDAQ:AGEN), La Jolla Pharmaceutical Company (NASDAQ:LJPC), Durata Therapeutics (NASDAQ:DRTX), Galmed Pharmaceuticals (NASDAQ:GLMD)

Kevin Long02 mins

Shares of Agenus Inc (NASDAQ:AGEN) , a biopharmaceutical company focused on developing novel immunotherapies to treat cancer and a number of other unmet diseases, tumbled by as much as 22% after partner GlaxoSmithKline (NYSE: GSK ) announced that its phase 3 MAGE-A3 cancer immunotherapeutic trial in non-small cell lung cancer (NSCLC) patients didn’t meet its…

Read More

Biotech New Highs: BioSpecifics Technologies (NASDAQ:BSTC), Five Prime Therapeutics (NASDAQ:FPRX), IGI Laboratories (NYSEMKT:IG), Durata Therapeutics (NASDAQ:DRTX)

Colin Pettis02 mins

BioSpecifics Technologies Corp. (NASDAQ:BSTC) is a biopharmaceutical company involved in the development of an injectable collagenase for multiple indications. BioSpecifics Technologies Corp. (NASDAQ:BSTC) stock performance was 2.14% in last session and finished the day at $27.16. Traded volume was 61,391.00 shares in the last session and the average volume of the stock remained 27,510.00 shares….

Read More

Eye Catching Stocks: Arch Coal Inc. (NYSE:ACI), Zynga Inc (NASDAQ:ZNGA), Microvision Inc. (NASDAQ:MVIS), Durata Therapeutics, Inc. (NASDAQ:DRTX), Territorial Bancorp Inc. (NASDAQ:TBNK)

Chris Lewis03 mins

Arch Coal Inc., (NYSE:ACI) a producer of the commodity in Appalachia and the western United States, rose the most in more than two months after reporting an increase in cash on hand and profit that beat analysts’ estimates. The company also said it had $1.05 billion of cash and short-term investments as of Sept. 30,…

Read More
Home